Global Vitamin B12 Series API Market Growth 2025-2031
Description
The global Vitamin B12 Series API market size is predicted to grow from US$ 145 million in 2025 to US$ 191 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Vitamin B12 series APIs are a group of pharmaceutical grade cobalt compounds, namely cobalamin, including cyanocobalamin, adenosylcobalamin, hydroxocobalamin and methylcobalamin. Vitamin B12 can be divided into pharmaceutical grade, food grade and feed grade. Vitamin B12 derivatives are generally pharmaceutical grade and used in medicines, including adenosylcobalamin, hydroxocobalamin and methylcobalamin.
Vitamin B12 belongs to the B vitamins and is an essential vitamin for humans and animals. Except for the presence of microorganisms such as sludge, it is not contained in animal and plant exogenous foods. Vitamin B12 must rely on the consumption of added foods to meet the needs of humans and animals. When the human body lacks vitamin B12, it causes many neurological diseases.
Before 1993, the production of vitamin B12 was small and the cost was high. Its price was similar to that of gold. The quality of vitamin B12 is constantly improving, the cost is constantly decreasing, and the amount is constantly increasing. In the past 20 years, the production industry and consumption field of vitamin B12 have been continuously expanding.
The global production capacity and output of vitamin B12 are mainly concentrated in China, accounting for about 80% of the world's production capacity. There are four major production companies in the country, including Hebei Yuxing, Hebei Huarong, North China Pharmaceutical, and Ningxia Kingvit. The production capacity, output and export volume of these four companies account for about 90% of the country, among which Hebei Yuxing is the world's largest supplier of vitamin B12.
The production of vitamin B12 requires high technical barrier and large investment, and an administrative licensing management system is implemented, so the production and operation threshold for entering the vitamin B12 industry is high.
LP Information, Inc. (LPI) ' newest research report, the “Vitamin B12 Series API Industry Forecast” looks at past sales and reviews total world Vitamin B12 Series API sales in 2024, providing a comprehensive analysis by region and market sector of projected Vitamin B12 Series API sales for 2025 through 2031. With Vitamin B12 Series API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vitamin B12 Series API industry.
This Insight Report provides a comprehensive analysis of the global Vitamin B12 Series API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vitamin B12 Series API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vitamin B12 Series API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vitamin B12 Series API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vitamin B12 Series API.
This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin B12 Series API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Cyanocobalamin
Mecobalamin
Cobamamide
Hydroxocobalamin
Segmentation by Application:
Oral Formulation
Injectable Formulation
Sprays
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hebei Yuxing Bio-Engineering
Hebei Huarong Pharmaceutical
Ningxia Kingvit Pharmaceutical
North China Pharmaceutical Company
EUROAPI
HTBA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vitamin B12 Series API market?
What factors are driving Vitamin B12 Series API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vitamin B12 Series API market opportunities vary by end market size?
How does Vitamin B12 Series API break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Vitamin B12 series APIs are a group of pharmaceutical grade cobalt compounds, namely cobalamin, including cyanocobalamin, adenosylcobalamin, hydroxocobalamin and methylcobalamin. Vitamin B12 can be divided into pharmaceutical grade, food grade and feed grade. Vitamin B12 derivatives are generally pharmaceutical grade and used in medicines, including adenosylcobalamin, hydroxocobalamin and methylcobalamin.
Vitamin B12 belongs to the B vitamins and is an essential vitamin for humans and animals. Except for the presence of microorganisms such as sludge, it is not contained in animal and plant exogenous foods. Vitamin B12 must rely on the consumption of added foods to meet the needs of humans and animals. When the human body lacks vitamin B12, it causes many neurological diseases.
Before 1993, the production of vitamin B12 was small and the cost was high. Its price was similar to that of gold. The quality of vitamin B12 is constantly improving, the cost is constantly decreasing, and the amount is constantly increasing. In the past 20 years, the production industry and consumption field of vitamin B12 have been continuously expanding.
The global production capacity and output of vitamin B12 are mainly concentrated in China, accounting for about 80% of the world's production capacity. There are four major production companies in the country, including Hebei Yuxing, Hebei Huarong, North China Pharmaceutical, and Ningxia Kingvit. The production capacity, output and export volume of these four companies account for about 90% of the country, among which Hebei Yuxing is the world's largest supplier of vitamin B12.
The production of vitamin B12 requires high technical barrier and large investment, and an administrative licensing management system is implemented, so the production and operation threshold for entering the vitamin B12 industry is high.
LP Information, Inc. (LPI) ' newest research report, the “Vitamin B12 Series API Industry Forecast” looks at past sales and reviews total world Vitamin B12 Series API sales in 2024, providing a comprehensive analysis by region and market sector of projected Vitamin B12 Series API sales for 2025 through 2031. With Vitamin B12 Series API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vitamin B12 Series API industry.
This Insight Report provides a comprehensive analysis of the global Vitamin B12 Series API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vitamin B12 Series API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vitamin B12 Series API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vitamin B12 Series API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vitamin B12 Series API.
This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin B12 Series API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Cyanocobalamin
Mecobalamin
Cobamamide
Hydroxocobalamin
Segmentation by Application:
Oral Formulation
Injectable Formulation
Sprays
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hebei Yuxing Bio-Engineering
Hebei Huarong Pharmaceutical
Ningxia Kingvit Pharmaceutical
North China Pharmaceutical Company
EUROAPI
HTBA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vitamin B12 Series API market?
What factors are driving Vitamin B12 Series API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vitamin B12 Series API market opportunities vary by end market size?
How does Vitamin B12 Series API break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
104 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Vitamin B12 Series API by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Vitamin B12 Series API by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
